Zoetis Inc Class A (ZTS)

Industry Drug Manufacturers - Specialty & Generic


This stock can be held in an Investment ISA and an Investment Account
Sell

$161.50

Buy

$169.00

arrow-up$2.26 (+1.37%)

Prices updated at 01 Mar 2025, 00:59 EST
| Prices minimum 15 mins delay
|
Prices in USD

Zoetis Inc is a developer and manufacturer of drugs providing medicines for animal health, and vaccines for livestock and companion animals. Its products are anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Profit margins

Created with Highcharts 7.2.2Gross margin (%)Operating margin (%)EBITDA margin (%)Net margin (%)20202021202220232024020406080

Valuation

Created with Highcharts 7.2.2Price earningsPrice / SalesPrice / Cash flow20212022202320242025020406080

Profit margins data table

Gross margin (%)
202470.62
202370.03
202269.63
202170.38
202069.18
201968.18
201867.19
201766.55
201665.92

Valuation data table

Price / Sales
20258.22
20248.14
202310.94
20228.65
202115.30
202012.12
201910.39
20187.30
20176.95
20165.47
20155.01
Price/Forward earnings (YTD)
27.78

Returns

Created with Highcharts 7.2.2Return on assets (%)Return on equity (%)Return on invested capital (%)202020212022202320240204060

Debt profile

Created with Highcharts 7.2.2Financial leverage2020202120222023202401234

Returns data table

Return on assets (%)
202417.43
202316.05
202214.67
202114.81
202013.02
201913.44
201814.75
201710.64
201610.55

Debt profile data table

YearFinancial leverage
20242.98
20232.86
20223.39
20213.06
20203.61
20194.26
20184.93
20174.85
20165.14
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.